Onglyza Class Action Lawsuit
Onglyza Can Cause Serious Heart Risks
If you or a loved one have suffered heart failure, congestive heart failure, cardiac complications or death while taking Onglyza or Kombiglyze XR to treat type 2 diabetes you may be entitled to compensation.
Onglyza (Saxagliptin) and Kombiglyze XR are prescription medications used to treat type 2 diabetes to help manage blood glucose levels. Two large clinical studies conducted on patients with heart disease showed that patients who received saxagliptin- or alogliptin-containing medicines were at a higher risk of heart failure compared to patients who received an inactive placebo treatment. The findings of the SAVOR trial were first reported in August 2013, which showed a 27% increase in the risk of hospitalization for heart failure among Onglyza users. In the saxagliptin and alogliptin trials, patients who received the drug were hospitalized at a higher rate that those receiving the placebo. Risk factors included a history of heart failure or kidney impairment.
Onglyza users have also reported other adverse events including:
- Heart Failure
- Congestive Heart Failure
- Cardiac Failure
Protect Your Rights
If you believe you or a loved one may have a claim, contact us today. There are time limits by which you need to file a product liability lawsuit against Onglyza. Those limits could time bar your case if it is not filed in a timely manner. Your state of residence, when you ingested the drug and when you experienced injuries could all affect how much time you have to file.
Complete the form and one of our attorneys will reach out to you within 24 hours to conduct a free and confidential evaluation of your case.
FREE CASE REVIEW
If you believe you or a loved one may have an Onglyza claim, contact us today. One of our attorneys will contact you within 24 hours to conduct a free and confidential evaluation of your case.